MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy

scientific article published on 12 September 2018

MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2018/6368309
P932PMC publication ID6157114
P698PubMed publication ID30276213

P50authorZhou LiqunQ82972233
Gengyan XiongQ85234378
Cong HuangQ91954579
Gang SongQ91954584
P2093author name stringHe Wang
Jie Li
Zhongcheng Xin
Yu Fan
Dong Fang
Yuke Chen
Guangjie Ji
P2860cites workIncidence and clinical significance of false-negative sextant prostate biopsies.Q52901252
Screening for prostate cancerQ57118172
Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implicationsQ71870897
Deciding whom to biopsyQ84979252
Prostate cancer: Urinary PCA3 and TMPRSS2:ERG reduce the need for repeat biopsyQ86082274
ESUR prostate MR guidelines 2012Q24620926
A systematic review of the diagnostic accuracy of prostate specific antigenQ33501864
Early detection of prostate cancer: AUA GuidelineQ33608474
Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancerQ33672510
Decision curve analysis: a novel method for evaluating prediction modelsQ34581068
Transrectal ultrasound in detecting prostate cancer compared with serum total prostate-specific antigen levelsQ37121973
A commentary on PSA velocity and doubling time for clinical decisions in prostate cancerQ38192156
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the LiteratureQ38346015
Management of men with previous negative prostate biopsyQ38868244
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentQ38939206
A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsyQ38957244
Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsiesQ39378933
Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary reportQ39517046
Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocolQ39594375
Serial biopsy results in prostate cancer screening studyQ39601460
Validation of a nomogram for predicting positive repeat biopsy for prostate cancerQ39704723
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialQ39752227
A novel nomogram to predict the probability of prostate cancer on repeat biopsyQ39846732
Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high gradeQ39857516
Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate samplingQ39931294
Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.Q40057890
Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?Q40211703
Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.Q40295325
Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy StrategiesQ42237453
Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trialQ43431647
Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate specific antigenQ44688339
Reply to Erik Rud and Eduard Baco's Letter to the Editor re: Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40.Q45942440
A graphical device to represent the outcomes of a logistic regression analysis.Q47392558
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.Q47621362
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)6368309
P577publication date2018-09-12
P1433published inBioMed Research InternationalQ17509958
P1476titleMultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
P478volume2018

Reverse relations

cites work (P2860)
Q92345413Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions
Q95261299Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patients

Search more.